The startup develops therapies that utilize mutualistic bacterial strains to synthesize polypeptide hormones in the gut microbiome, targeting metabolic and age-related disorders. This approach aims to reduce the prevalence of conditions such as obesity, diabetes, osteoporosis, and Parkinson's disease by enhancing metabolic and brain function.
Funding
$590K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Metabolic and age-related disorders, such as obesity, diabetes, osteoporosis, and Parkinson's disease, pose significant challenges to global health. Current treatments often have limited efficacy or undesirable side effects. There is a need for novel therapeutic approaches that can address the underlying causes of these conditions.
Solution
This startup is developing a novel class of therapies that leverage mutualistic bacterial strains to synthesize polypeptide hormones directly within the gut microbiome. By engineering these bacteria to produce specific hormones, the company aims to modulate metabolic pathways and improve overall health. This approach has the potential to address the root causes of metabolic and age-related disorders by enhancing metabolic and brain function. The localized production of hormones in the gut may also reduce systemic side effects compared to traditional hormone therapies.
Target Audience
The primary target audience includes individuals at risk of or suffering from metabolic and age-related disorders, such as obesity, diabetes, osteoporosis, and Parkinson's disease, as well as healthcare providers specializing in these conditions.
Features
- Engineered bacterial strains capable of synthesizing specific polypeptide hormones within the gut.
- Targeted delivery of therapeutic hormones directly to the site of action.
- Modulation of metabolic pathways to address the underlying causes of metabolic disorders.
- Potential for improved efficacy and reduced side effects compared to traditional hormone therapies.
- Oral administration for convenient and non-invasive treatment.